Steven Damon

Vice President, Business & Commercial Development, Femasys-a Women's Health Company

Mr. Damon has over 25 years of experience with various business roles in the medical device and pharmaceutical industries. Prior to his current role at Femasys he served as the President and CEO of 4P Therapeutics, a company he founded in 2011 and sold to Nutriband Inc. in 2018. Before founding 4P Therapeutics, Steve led partnership and funding efforts at Altea Therapeutics as the company’s Senior Vice President of Business and Corporate Development. Prior to joining Altea Therapeutics, Steven Damon was a member of the executive management team at Durect Corporation in Cupertino, Ca, where he served as Executive Director for Business and Corporate Development. In addition, Steve was the President of Absorbable Polymers International a Birmingham, Alabama company he founded which became a wholly owned subsidiary of Durect Corporation. He was previously a senior management member of the Professional Health Care team at Kimberly-Clark Corporation, with lead responsibilities for commercial development of the healthcare business in Europe and key responsibilities for a number of major acquisition deals.

In addition to his Director role with Temple Therapeutics, Steve serves on the Board of Directors for Nutriband Inc., Micron BioMedical and Georgia BIO.  He also serves as a mentor for the Georgia Tech and Emory TiGER program.  Steve has maintained Business and Corporate Development consultant roles throughout his career including supporting the sale of Map Pharmaceuticals to Allergan.   


MeEt Us

View our upcoming events

View All Events